SF3B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.532800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.157400E-01
Normal-vs-Stage2
6.689800E-01
Normal-vs-Stage3
3.403400E-01
Normal-vs-Stage4
8.169800E-01
Stage1-vs-Stage2
6.911400E-01
Stage1-vs-Stage3
4.350000E-01
Stage1-vs-Stage4
3.341400E-01
Stage2-vs-Stage3
1.999620E-01
Stage2-vs-Stage4
7.575200E-01
Stage3-vs-Stage4
2.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.595600E-01
Normal-vs-AfricanAmerican
8.628800E-01
Normal-vs-Asian
3.904600E-01
Caucasian-vs-AfricanAmerican
6.608600E-01
Caucasian-vs-Asian
5.135000E-01
AfricanAmerican-vs-Asian
3.323400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.772800E-01
Normal-vs-Female
6.276200E-01
Male-vs-Female
7.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.210000E-01
Normal-vs-Age(41-60Yrs)
9.664000E-01
Normal-vs-Age(61-80Yrs)
5.131400E-01
Normal-vs-Age(81-100Yrs)
9.020800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.240990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.271000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.741200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.781400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.992800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.384000E-01
Normal-vs-Daily Drinker
7.548600E-01
Normal-vs-Weekly Drinker
6.743600E-01
Normal-vs-Occasional Drinker
6.923800E-01
Normal-vs-Social Drinker
6.294600E-01
Non Drinker-vs-Daily Drinker
2.150200E-01
Non Drinker-vs-Weekly Drinker
5.257400E-01
Non Drinker-vs-Occasional Drinker
7.876900E-03
Non Drinker-vs-Social Drinker
2.264200E-01
Daily Drinker-vs-Weekly Drinker
7.383000E-01
Daily Drinker-vs-Occasional Drinker
1.964240E-01
Daily Drinker-vs-Social Drinker
9.691200E-01
Weekly Drinker-vs-Occasional Drinker
2.101600E-01
Weekly Drinker-vs-Social Drinker
7.597000E-01
Occasional Drinker-vs-Social Drinker
1.216180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.243400E-01
Normal-vs-Grade 2
9.702400E-01
Normal-vs-Grade 3
9.701400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.629800E-01
Grade 1-vs-Grade 3
1.655590E-02
Grade 1-vs-Grade 4
9.243400E-01
Grade 2-vs-Grade 3
3.562000E-02
Grade 2-vs-Grade 4
9.702400E-01
Grade 3-vs-Grade 4
9.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.704200E-01
Normal-vs-NonDiabetic
6.949400E-01
Diabetic-vs-NonDiabetic
4.551200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.630000E-01
Normal-vs-NoPancreatitis
6.149800E-01
Pancreatitis-vs-NoPancreatitis
8.936100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.030800E-01
Normal-vs-N1
6.299600E-01
N0-vs-N1
3.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.762000E-01
Normal-vs-TP53-NonMutant
5.310800E-01
TP53-Mutant-vs-TP53-NonMutant
5.394200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
